Papers
List our Papers
The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression.
Maffei M, Montemiglio LC, Vitagliano G, Fedele L, Sellathurai S, Bucci F, Compagnone C, Chiarini V, Exertier C, Muzi A, Roscilli G, Vallone B, Marra E.
Biomolecules 2021, 11(12), 1812;
Toxicity and Local Tolerance of COVID- e Vax, a Plasmid DNA Vaccine for SARS-CoV-2, Delivered by Electroporation.
Ramot Y, Caselli G, Aurisicchio L, Andreini I, Marra E, Luberto L, Stoppoloni D, Pacello ML, Monetini L, Nyska A.
Toxicol Pathol 2021 Oct;49(7):1255-1268. doi: 10.1177/01926233211042263. Epub 2021 Sep 8.
Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition.
Lione L, Salvatori E, Petrazzuolo A, Massacci A, Maggio R, Conforti A, Compagnone M, Aurisicchio L, Ciliberto G, Palombo F.
Oncoimmunology. 2021; 10(1): 1898832. doi: 10.1080/2162402X.2021.1898832
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
Salvatori G, Luberto L, Maffei M, Aurisicchio L, Roscilli G, Palombo F, Marra E.
J Transl Med 2020 Jun 3;18(1):222. doi: 10.1186/s12967-020-02392-y.
Are Genetic Vaccines the Right Weapon against COVID-19?
Conforti A, Marra E, Roscilli G, Palombo F, Ciliberto G, Aurisicchio L.
Mol Ther 2020 Jul 8;28(7):1555-1556. doi: 10.1016/j.ymthe.2020.06.007. Epub 2020 Jun 10.